ASH HIGHLIGHTS 2024 – MULTIPLE MYELOMA ROUNDTABLE DISCUSSIONS: Phase 3 Auriga Study Among Clinically Relevant Subgroups

ASH HIGHLIGHTS 2024 – MULTIPLE MYELOMA ROUNDTABLE DISCUSSIONS: Phase 3 Auriga Study Among Clinically Relevant Subgroups

ASH HIGHLIGHTS 2024 ROUNDTABLE DISCUSSIONS
Icon Chair Speaker

Chair

Dr. Donna Reece

Icon Chair Speaker

Speaker

Dr. Darrell White

Dr. Maria Victoria Mateos Manteca

Tagged